Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Sandig

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Biotechnology and Bioengineering|February 6, 2020
A dynamic model linking cell growth to intracellular metabolism and extracellular by-product accumulationJoão R C Ramos, Alexander G Rath, Yvonne Genzel, et al.
Infectious Disorders Drug Targets|April 20, 2022
A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 PatientsTibor Bakacs, Volker Sandig, Shimon Slavin, et al.
Vaccine|May 5, 2009
Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutininJana Schwarzer, Erdmann Rapp, René Hennig, et al.
BMC Biotechnology|November 1, 2012
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cellsVerena Lohr, Yvonne Genzel, Ingo Jordan, et al.
Journal of Proteome Research|October 29, 2014
Rapid analysis of cell surface N-glycosylation from living cells using mass spectrometryHouda Hamouda, Matthias Kaup, Mujib Ullah, et al.
Vaccine|July 4, 2019
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systemsJuliana Coronel, Ilona Behrendt, Tim Bürgin, et al.
Vaccines|January 8, 2025
Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA)Sirine Abidi, Aurora Elhazaz Fernandez, Nicole Seehase, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 4, 2023
Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximabYan Felix Karl Dyck, Daniel Rehm, Karsten Winkler, et al.
Vaccines|July 30, 2025
Replication of Vectored Herpesvirus of Turkey (HVT) in a Continuous, Microcarrier-Independent Suspension Cell Line from Muscovy DuckKaroline Mähl, Deborah Horn, Sirine Abidi, et al.
Journal of Virology|August 28, 2004
Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific mannerDmitry M Shayakhmetov, Zong-Yi Li, Anuj Gaggar, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Biotechnology and Bioengineering|February 6, 2020
A dynamic model linking cell growth to intracellular metabolism and extracellular by-product accumulationJoão R C Ramos, Alexander G Rath, Yvonne Genzel, et al.
Infectious Disorders Drug Targets|April 20, 2022
A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 PatientsTibor Bakacs, Volker Sandig, Shimon Slavin, et al.
Vaccine|May 5, 2009
Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutininJana Schwarzer, Erdmann Rapp, René Hennig, et al.
BMC Biotechnology|November 1, 2012
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cellsVerena Lohr, Yvonne Genzel, Ingo Jordan, et al.
Journal of Proteome Research|October 29, 2014
Rapid analysis of cell surface N-glycosylation from living cells using mass spectrometryHouda Hamouda, Matthias Kaup, Mujib Ullah, et al.
Vaccine|July 4, 2019
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systemsJuliana Coronel, Ilona Behrendt, Tim Bürgin, et al.
Vaccines|January 8, 2025
Expression of an Efficient Selection Marker Out of a Duplicated Site in the ITRs of a Modified Vaccinia Virus Ankara (MVA)Sirine Abidi, Aurora Elhazaz Fernandez, Nicole Seehase, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 4, 2023
Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximabYan Felix Karl Dyck, Daniel Rehm, Karsten Winkler, et al.
Vaccines|July 30, 2025
Replication of Vectored Herpesvirus of Turkey (HVT) in a Continuous, Microcarrier-Independent Suspension Cell Line from Muscovy DuckKaroline Mähl, Deborah Horn, Sirine Abidi, et al.
Journal of Virology|August 28, 2004
Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific mannerDmitry M Shayakhmetov, Zong-Yi Li, Anuj Gaggar, et al.
Pageof 7